Rokos Capital Management LLP Bristol Myers Squibb CO Transaction History

Rokos Capital Management LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $19.3 Million - $21.6 Million	333,934 New	333,934 $19.4 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $23.7 Million - $26.1 Million	-326,227 Reduced 64.65%	178,400 $13.7 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $31 Million - $37.2 Million	504,627 New	504,627 $37 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $31 Million - $37.2 Million	-504,627 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $27.1 Million - $31.5 Million	504,627 New	504,627 $31.7 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $67.8 Million - $79.4 Million	-1,145,738 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $70.9 Million - $77.2 Million	1,145,738 New	1,145,738 $76.6 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Rokos Capital Management LLP with notifications on news.